You have 9 free searches left this month | to do more

cladribine

Cladribine is a drug used to treat Acute Myeloid Leukemia, Leukemia, Multiple Sclerosis, and other conditions. Cladribine is being actively studied in 30 studies and prior, has been studied in 29.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterFred Hutch/University of Washington Cancer ConsortiumChun Wang
Fred Hutchinson Cancer CenterM D Anderson Cancer CenterJie Ji
University of WashingtonMayo Clinic Cancer CenterAnna Halpern
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Hairy Cell Leukemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
M
Recruiting
  • Leukemia
  • Cladribine
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-11
Nov 11, 2021
U
Recruiting
  • Multiple Sclerosis
  • Cladribine
  • Dallas, Texas
    UT Southwestern Medical center
2022-02-10
Feb 10, 2022
W
Recruiting
  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • Cladribine
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-10-01
Oct 1, 2021
M
Active, not recruiting
  • Relapsing Multiple Sclerosis (RMS)
  • Cladribine
  • +2 more
  • Bochum, Germany
  • +6 more
2022-02-08
Feb 8, 2022
M
Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-01
Feb 1, 2022
A
Active, not recruiting
  • Langerhans Cell Histiocytosis of Lung
  • Cladribine
  • Paris, France
    Saint Louis hospital
2021-02-17
Feb 17, 2021
M
Not yet recruiting
  • Acute Myeloid Leukemia Myelodysplastic Syndromes
  • Cladribine
  • Gliwice, Poland
    Klinika Transplantacji Szpiku i Onkohematologii Narodowy Instytu
2021-05-03
May 3, 2021
M
Recruiting
  • Secondary Acute Myeloid Leukemia
  • Cladribine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-06-25
Jun 25, 2021
M
Completed
  • Untreated Adult Acute Myeloid Leukemia
  • Cladribine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2020-11-28
Nov 28, 2020
S
Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Cladribine
  • +5 more
  • Foshan, Guangdong, China
  • +8 more
2022-03-28
Mar 28, 2022
M
Recruiting
  • Acute Myeloid Leukemia
  • Lintuzumab-Ac-225 (Dose 1: 0.25 μCi/kg Ac-225 with 1.6 μg/kg lintuzumab)
  • +8 more
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
2021-05-14
May 14, 2021
M
Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Cladribine
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-15
Feb 15, 2022
S
Recruiting
  • High Risk Acute Myeloid Leukemia
  • Allogeneic Hematopoeitic Stem Cell Transplantation
  • Cladribine
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai general hospital, Shanghai Jiaotong university school o
2021-10-10
Oct 10, 2021
S
Recruiting
  • High Risk Acute Myeloid Leukemia
  • Allogeneic Hematopoeitic Stem Cell Transplantation
  • Cladribine
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai general hospital, Shanghai Jiaotong university school o
2021-10-10
Oct 10, 2021
O
Recruiting
  • Relapsing Multiple Sclerosis
  • Multiple Sclerosis
  • Rituximab
  • Cladribine
  • Drammen, Buskerud, Norway
  • +10 more
2020-11-02
Nov 2, 2020
P
Not yet recruiting
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
  • Cladribine
  • (no location specified)
2020-12-17
Dec 17, 2020
L
Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    Long Zhao
2021-10-07
Oct 7, 2021
M
Enrolling by invitation
  • Multiple Sclerosis
  • Adherence, Medication
  • Cladribine
  • +3 more
  • Melbourne, Victoria, Australia
    Monash University
2020-12-16
Dec 16, 2020
F
Recruiting
  • Acute Myeloid Leukemia
  • Myeloid Neoplasm
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-15
Mar 15, 2022
U
Completed
  • Lymphoma
  • +3 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
2019-12-16
Dec 16, 2019
S
Unknown status
  • Acute Myeloid Leukemia
  • Relapse Leukemia
  • Cladribine
  • +3 more
  • Guangzhou, Guangdong, China
    Liang Wang
2019-08-18
Aug 18, 2019
M
Recruiting
  • Hairy Cell Leukemia
  • Recurrent Hairy Cell Leukemia
  • Cladribine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2020-03-20
Mar 20, 2020
S
Unknown status
  • Acute Lymphoblastic Leukemia
  • Cladribine
  • +3 more
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
2019-08-18
Aug 18, 2019